Nucleotide analogs
US-2018320219-A1 · Nov 8, 2018 · US
US11530235B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11530235-B2 |
| Application number | US-201916715907-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2019 |
| Priority date | Nov 20, 2015 |
| Publication date | Dec 20, 2022 |
| Grant date | Dec 20, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Mutant mono ADP-ribose-polymerases (mono-PARP) proteins and small molecule compound substrates specific for the mutant mono-PARP proteins as well as methods of using these compositions to identify protein targets of the mono-PARPs and to screen for antagonists of the mono-PARPs are described.
Opening claim text (preview).
The invention claimed is: 1. A method of identifying a protein target of a mono-PARP, the method comprising: contacting a small molecule compound (SMC) of formula: wherein R is alkyl or aryl, with a protein, said protein comprising a polypeptide comprising a mono-poly-ADP-ribose-polymerases (PARP) catalytic domain comprising SEQ ID NO: 15, and wherein the polypeptide catalyzes the addition of the SMC to a PARP protein target, wherein said contacting occurs within a living cell; subjecting the cell to conditions that result in the protein catalyzing the reaction by which the SMC is covalently attached to one or more cellular proteins; and identifying the one or more cellular proteins to which the SMC is covalently attached as the protein target(s) of the mono-PARP. 2. The method of claim 1 , wherein the SMC comprises 5-Bn-6-a-NAD+. 3. The method of claim 1 , further comprising conjugating a label to the SMC. 4. The method of claim 3 , wherein the label comprises biotin or a fluorescent molecule. 5. The method of claim 1 , further comprising detecting the one or more cellular proteins to which the SMC is covalently attached via a method that comprises mass spectrometry. 6. The method of claim 1 , wherein R is aryl. 7. The method of claim 6 , wherein R is benzyl. 8. The method of claim 1 , wherein R is alkyl. 9. The method of claim 8 , wherein R is C 1-6 alkyl. 10. The method of claim 9 , wherein R is selected from the group of methyl, isobutyl, and propyl.
the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide · CPC title
involving transferase · CPC title
involving cells · CPC title
NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase · CPC title
Pentosyltransferases (2.4.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.